111, Inc. (NASDAQ:YI ) Q4 2024 Earnings Conference Call March 20, 2025 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Robert Sassoon - Water Tower Research Shifan Sun - CICC Zoe Bian - Citi Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
111, Inc. (NASDAQ:YI ) Q2 2024 Earnings Conference Call August 29, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Conference Call Participants Xipeng Feng - CICC Zoe Bian - Citi Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
| Pharmaceuticals Industry | Healthcare Sector | Junling Liu CEO | XDUS Exchange | US68247Q2012 ISIN |
| CN Country | 1,238 Employees | - Last Dividend | - Last Split | 12 Sep 2018 IPO Date |
111, Inc., is a prominent entity in the healthcare market of the People's Republic of China, leveraging an innovative blend of online and offline platforms to serve a wide spectrum of health-related consumer needs. Operating through two distinct segments, B2C (Business to Consumer) and B2B (Business to Business), the company distinguishes itself by offering a comprehensive range of medical and wellness products alongside value-added services. It aims at streamlining the procurement of healthcare products and enhancing accessibility to healthcare services for consumers across China. Founded in 2010 and undergoing a name change from New Peak Group to 111, Inc. in April 2018, the company positions itself as a key player in transforming the healthcare landscape by integrating digital solutions. With its headquarters in Shanghai, it extends its services across various Chinese provinces through both its online platforms and offline Yi Hao Pharmacy stores.
Medical and Wellness Products: 111, Inc. offers an extensive range of medical products through its online retail, and wholesale and retail pharmacies. This includes:
Value-Added Services: Beyond product offerings, 111, Inc. enhances its value proposition through several service offerings. These include: